AMN Healthcare Services delivered second quarter results that exceeded Wall Street’s expectations, with management attributing the strong performance primarily to robust demand in its Nurse and Allied Solutions segment. CEO Caroline Grace pointed to travel nurse and allied staffing volumes growing at their highest rate in four years, reflecting both increased patient demand and AMN’s focused investments in automation and technology-driven fulfillment. The company also benefited from higher-than-expected labor disruption revenue and improved execution in its search and international nurse businesses, helping lift both revenue and margins for the quarter.
Is now the time to buy AMN? Find out in our full research report (it’s free for active Edge members).
AMN Healthcare Services (AMN) Q2 CY2026 Highlights:
- Revenue: $673.2 million vs analyst estimates of $628.2 million (2.3% year-on-year growth, 7.2% beat)
- Adjusted EPS: $0.77 vs analyst estimates of $0.19 (significant beat)
- Adjusted EBITDA: $73.36 million vs analyst estimates of $43.27 million (10.9% margin, 69.5% beat)
- Revenue Guidance for Q3 CY2026 is $647.5 million at the midpoint, above analyst estimates of $618.2 million
- Operating Margin: 4%, up from -18.8% in the same quarter last year
- Sales Volumes were up 5.7% year on year
- Market Capitalization: $1.26 billion
While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions From AMN Healthcare Services’s Q2 Earnings Call
- Jeffrey Silber (BMO Capital Markets) asked about trends in contingent labor premiums and penetration rates. CEO Caroline Grace explained that contingent premiums have returned to historic lows and utilization levels are at or slightly below pre-pandemic norms, with flexibility and cost-effectiveness driving adoption.
- Albert Rice (UBS) probed margin assumptions and segment mix for next quarter. CFO Brian Scott clarified that core margins are expected to remain stable, with the main change driven by lower contribution from high-margin labor disruption revenue and a greater mix from lower-margin segments.
- Tobey Sommer (Truist Securities) questioned whether rising order volumes would lead to higher bill rates. Grace noted that while current bill rates remain stable, sustained demand could eventually push rates higher, though industry competition is keeping rates in check for now.
- Kevin Fischbeck (Bank of America) inquired about recent acquisitions and AMN’s approach to industry consolidation. Scott responded that the balance sheet now allows for more active M&A participation, and Grace added that competitive changes are also opening new market opportunities for AMN.
- Mark Marcon (Baird) asked about drivers behind hospital permanent hiring slowdowns. Grace cited normalized hiring and retention rates post-pandemic, along with cost optimization and flexibility as reasons for increased contingent labor usage.
Catalysts in Upcoming Quarters
In the coming quarters, the StockStory team will be watching (1) whether double-digit growth in travel nurse and allied staffing is sustained amid fluctuating hospital demand, (2) the pace and impact of AMN’s technology platform enhancements and AI-driven recruiting on fill rates, and (3) the outcome of ongoing industry consolidation efforts, including AMN’s ability to deploy capital for strategic acquisitions. We will also monitor margin trends as the business mix evolves.
AMN Healthcare Services currently trades at $33.00, up from $30.80 just before the earnings. Is the company at an inflection point that warrants a buy or sell? See for yourself in our full research report (it’s free).
Our Favorite Stocks Right Now
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.
